Knödler, M., Körfer, J., Kunzmann, V., Trojan, J., Daum, S., Schenk, M., . . . Lordick, F. (2018). Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer. Br J Cancer.
Citação norma ChicagoKnödler, Maren, et al. "Randomised Phase II Trial to Investigate Catumaxomab (anti-EpCAM × anti-CD3) for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Cancer." Br J Cancer 2018.
Citação norma MLAKnödler, Maren, et al. "Randomised Phase II Trial to Investigate Catumaxomab (anti-EpCAM × anti-CD3) for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Cancer." Br J Cancer 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.